Pharmacoeconomics of Bisphosphonates for Skeletal-Related Event Prevention in Metastatic Non-Breast Solid Tumours

Author： Carter John A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.5, 2012-05, pp. : 373-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Denosumab: In the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumours

By Scott Lesley J.   Muir Victoria J.  

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 1059-1069

Adis International

Access to resources Recommend Favorite

The Clinical and Cost Considerations of Bisphosphonates in Preventing Bone Complications in Patients with Metastatic Breast Cancer or Multiple Myeloma

By McCloskey E.V.  

Drugs, Vol. 61, Iss. 9, 2001-01 ,pp. : 1253-1274

Adis International

Access to resources Recommend Favorite

The Role of Bisphosphonates in Breast Cancer

By Theriault Richard L.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 232-241

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer

By Zeliadt Steven B.   Penson David F.  

PharmacoEconomics, Vol. 25, Iss. 4, 2007-01 ,pp. : 309-327

Adis International

Access to resources Recommend Favorite

Therapeutic Approach of Primary Bone Tumours by Bisphosphonates

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 2981-2987

Bentham Science Publishers

Access to resources Recommend Favorite